Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05458362 · ClinicalTrials.gov registry record · NA
Brief Enhanced Anxiety Sensitivity Treatment (Group)
A NA study, sponsored by Ohio University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT05458362 is a NA study that has completed, run by Ohio University. The registered enrollment target is 73 participants.
The verdict
NCT05458362, a NA study, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
One-third of the U.S. population experience anxiety disorders in their lifetime and only 25% of them seek treatment, reporting logistics and cost of treatment among the primary barriers. A potential way to prevent and treat multiple anxiety disorders is to target the risk factors that contribute to their etiology. One such well-researched risk factor is anxiety sensitivity (AS), a fear of anxiety-related sensations. Given a need for affordable and accessible brief treatments, we and our colleagues have been iteratively developing Brief Enhanced Anxiety Sensitivity Treatment (BEAST), a one-session virtual treatment targeting AS. Older versions of BEAST include psychoeducation, interoceptive exposure (IE), and IE homework. Several studies showed that the previous versions of BEAST reduced AS and, through the reductions in AS, they also reduced anxiety. However, the effect sizes for the decrease in anxiety were modest. Efficacy and personalization may be improved using Ecological Momentary Intervention (EMI). EMI delivers brief interventions remotely in real-time and in natural settings. The goal of the current study is to test the efficacy of adding EMI to BEAST. Participants will be randomly assigned to EMI and control (no EMI) conditions. All participants will receive a virtual 1.5-hour-long intervention group session facilitated by a therapist. The EMI group will receive individualized intervention messages helping them to use new skills for two weeks after the session. After the two-week EMI period, all participants will complete post-treatment measures of AS and anxiety. A month later, they will complete a follow-up assessing AS and anxiety. The efficacy of the EMI component in reducing AS and anxiety will be tested using multilevel modeling. Improving the efficacy of BEAST, while keeping it brief, affordable, and accessible online, is an important step towards making it a treatment that may be used on a large scale.
Interventions
- BEHAVIORAL Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST)
- BEHAVIORAL Control group Anxiety Sensitivity Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2022-07-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05458362
The ClinicalTrials.gov registry entry for NCT05458362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST) is the first listed.
NCT05458362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05458362 about?
NCT05458362 is a clinical study titled "Brief Enhanced Anxiety Sensitivity Treatment (Group)". One-third of the U.S. population experience anxiety disorders in their lifetime and only 25% of them seek treatment, reporting logistics and cost of treatment among the primary barriers. A potential way to prevent and treat multiple anxiety disorders is to target the risk factors that contribute to ...
What is the current status of trial NCT05458362?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2022-02-09. Estimated completion is 2022-07-04.
What interventions are being tested in trial NCT05458362?
The interventions under investigation include: Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST) (BEHAVIORAL), Control group Anxiety Sensitivity Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05458362?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.